O Akingbade1, S Balogun1, D Ojo1, P Akinduti2, P O Okerentugba3, J C Nwanze4, I O Okonko3. 1. Department of Microbiology, Federal University of Agriculture, Abeokuta, Nigeria. 2. Department of Medical Microbiology & Parasitology, Olabisi Onabanjo University, Ago-Iwoye, Nigeria. 3. Medical Microbiology Unit, Department of Microbiology, University of Port Harcourt, East- West Road, P.M.B. 5323, Choba, Port Harcourt, Rivers State, Nigeria. 4. Department of Pharmacology and Therapeutics, Igbinedion University, Okada, Edo State, Nigeria.
Abstract
BACKGROUND: Multi-drug resistant Escherichia coli has become a major threat and cause of many urinary tract infections (UTIs) in Abeokuta, Nigeria. OBJECTIVES: This study was carried out to determine the resistant plasmids of multidrug resistant Escherichia coli isolated from (Urinary tract infections)UTIs in Abeokuta. METHODS: A total of 120 Escherichia coli isolates were obtained from urine samples collected from patients attending inpatient and outpatient clinics presenting UTI; with their biodata. Antibiotics susceptibility was performed and multi-drug resistant isolates were selected for plasmid profiling. Plasmids were extracted by the alkaline lysis method, electrophoresed on 0.8% agarose gel and profiled using a gel-photo documentation system gel. RESULTS: Escherichia coli isolates obtained shows high resistance to cloxacillin (92.5%), amoxicillin (90.8%), ampicillin (90.8%), erythromycin (75.8%), cotrimoxazole (70.0%), streptomycin (70.0%) and tetracycline (68.3%) while 85.8% and 84.2% were susceptible to gentamycin and ceftazidime respectively. Sixteen Escherichia coli strains were observed to be resistant to more than two classes of antibiotics. The resistant plasmid DNA was detectable in 6(37.5%) of the 16 multidrug resistant Escherichia coli having single sized plasmids of the same weight 854bp and were all resistant to erythromycin, cefuroxime, cloxacillin, amoxicillin, ampicillin and cotrimoxazole. CONCLUSION: This study has highlighted the emergence of multidrug resistant R-plasmids among Escherichia coli causing urinary tract infections in Abeokuta, Nigeria. There is a high level of resistance to many antimicrobials that are frequently used in Abeokuta, Nigeria.
BACKGROUND: Multi-drug resistant Escherichia coli has become a major threat and cause of many urinary tract infections (UTIs) in Abeokuta, Nigeria. OBJECTIVES: This study was carried out to determine the resistant plasmids of multidrug resistant Escherichia coli isolated from (Urinary tract infections)UTIs in Abeokuta. METHODS: A total of 120 Escherichia coli isolates were obtained from urine samples collected from patients attending inpatient and outpatient clinics presenting UTI; with their biodata. Antibiotics susceptibility was performed and multi-drug resistant isolates were selected for plasmid profiling. Plasmids were extracted by the alkaline lysis method, electrophoresed on 0.8% agarose gel and profiled using a gel-photo documentation system gel. RESULTS:Escherichia coli isolates obtained shows high resistance to cloxacillin (92.5%), amoxicillin (90.8%), ampicillin (90.8%), erythromycin (75.8%), cotrimoxazole (70.0%), streptomycin (70.0%) and tetracycline (68.3%) while 85.8% and 84.2% were susceptible to gentamycin and ceftazidime respectively. Sixteen Escherichia coli strains were observed to be resistant to more than two classes of antibiotics. The resistant plasmid DNA was detectable in 6(37.5%) of the 16 multidrug resistant Escherichia coli having single sized plasmids of the same weight 854bp and were all resistant to erythromycin, cefuroxime, cloxacillin, amoxicillin, ampicillin and cotrimoxazole. CONCLUSION: This study has highlighted the emergence of multidrug resistant R-plasmids among Escherichia coli causing urinary tract infections in Abeokuta, Nigeria. There is a high level of resistance to many antimicrobials that are frequently used in Abeokuta, Nigeria.
Authors: M Iqbal; I K Patel; S H Shah; Q Ain; N Barney; Q Kiani; K Z Rabbani; G Zaidi; B Mehdi Journal: J Pak Med Assoc Date: 2002-09 Impact factor: 0.781
Authors: J I Alós; J L Gómez-Garcés; I García-Bermejo; J J García-Gómez; R González-Palacios; B Padilla Journal: Med Clin (Barc) Date: 1993-06-12 Impact factor: 1.725
Authors: John M Stelling; Karin Travers; Ronald N Jones; Philip J Turner; Thomas F O'Brien; Stuart B Levy Journal: Emerg Infect Dis Date: 2005-06 Impact factor: 6.883
Authors: Kathleen M Powis; Sajini Souda; Shahin Lockman; Gbolahan Ajibola; Kara Bennett; Jean Leidner; Michael D Hughes; Sikhulile Moyo; Erik van Widenfelt; Haruna B Jibril; Joseph Makhema; Max Essex; Roger L Shapiro Journal: J Int AIDS Soc Date: 2017-11 Impact factor: 5.396